1. World health report 2001;World Health Organization,2001
2. Global surveillance for antituberculosis‐drug resistance, 1994–1997. World Health Organization–International Union against Tuberculosis and Lung Disease Working Group on Anti‐Tuberculosis Drug Resistance Surveillance;Pablos‐Mendez;N Engl J Med,1998
3. Die Behandlung der Tuberkulose mit Neoteben (Isonikotinsäurehydrazid);Domagk;Deutsch Med Wschr,1952
4. The absorption, distribution, excretion, and short‐term toxicity of isonicotinic acid hydrazide (nydrazid) in man;Elmendorf;Am Rev Tuberc,1952
5. Hydrazine derivatives of isonicotinic acid (rimifon, marsilid) in the treatment of active progressive caseous‐pneumonic tuberculosis; a preliminary report;Robitzek;Am Rev Tuberc,1952